Dr. Kevin Selting

Increasing p53 protein sensitizes non-small cell lung cancer to paclitaxel and cisplatin in vitro

The Quality Of Evidence In Preclinical Medical Education Literature: A Systematic Review

Serum alhpa 1-acid glycoprotein concentrations in healthy and tumor-bearing cats

Echocardiographic assessment of hemodynamic changes produced by two methods of inducing fluid deficit in dogs

Immunohistochemical detection of retinoid receptors in tumors from 30 dogs diagnosed with cutaneous lymphoma

Clinical Evaluation of Tavocept to Decrease Diuresis Time and Volume in Dogs with Bladder Cancer Receiving Cisplatin

Hemodynamic and biochemical alterations in dogs with lymphoma after induction of chemotherapy

Evaluation of satraplatin in dogs with spontaneously occurring malignant tumors

Bisphosphonates and cancer

Phase I dose escalation safety study of nanoparticulate paclitaxel (CTI 52010) in normal dogs

Gum arabic-coated radioactive gold nanoparticles cause no short-term local or systemic toxicity in the clinically relevant canine model of prostate cancer

Radiation Safety Considerations in the Treatment of Canine Skeletal Conditions Using 153Sm, 90Y, and 117mSn